The partners aim to develop AI-powered, real-time, personalized brain-computer interface therapies for neurological disorders ...
Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish ...
INBRAIN partners with Microsoft to use agentic AI and Azure cloud tech for next-gen brain-computer therapeutics.
Cognixion’s Vision Pro study shows how Apple’s accessibility framework is shaping the future of healthcare and communication ...
Electroencephalography (EEG) is a fascinating noninvasive technique that measures and records the brain's electrical activity ...
The funds are expected to accelerate commercialization of the company’s Stentrode BCI platform, while advancing development ...
A copy of the schedule obtained by POLITICO shows health agencies’ leaders and health tech CEOs speaking at the Wednesday ...
SCI Ventures’ investment in Precision reflects the firm's belief in the potential impact of the BCI field. The fund provides not only capital but also deep networks of clinicians, regulatory experts, ...
INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced a strategic collaboration with Microsoft to explore ...
Australia has invested $54 million in Melbourne-born brain-computer interface company Synchron, the federal government’s National Reconstruction Fund Corporation (NRFC) announced on Thursday.
The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...
Medical Device Network on MSN
InBrain collaborates with Microsoft to advance BCI with agentic AI
InBrain Neuroelectronics has partnered with Microsoft to explore how it can advance precision neurology by applying agentic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback